Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer

BACKGROUND: The safety of thoracic radiotherapy (TRT) after programmed death 1/programmed death ligand 1 (PD‐(L)1) inhibitor treatment in patients with lung cancer was scarcely reported. This retrospective study was conducted to evaluate the incidence, severity, and risk factors of symptomatic treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu, Liu, Xinchao, Huang, Zhaoqin, Zhao, Kaikai, Wang, Yao, Ren, Fei, Yu, Jinming, Meng, Xiangjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633221/
https://www.ncbi.nlm.nih.gov/pubmed/34664788
http://dx.doi.org/10.1002/cam4.4363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633221/
https://www.ncbi.nlm.nih.gov/pubmed/34664788
http://dx.doi.org/10.1002/cam4.4363

Ejemplares similares